Showing results (191-200 of 274) with videos related to

Sort By:
Pageof 28
Age and Ageing|April 27, 2017
Effectiveness of in-hospital geriatric co-management: a systematic review and meta-analysisBastiaan Van Grootven, Johan Flamaing, Bernadette Dierckx de Casterlé, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 25, 2018
The Tryton® dedicated bifurcation stent: Five-year clinical outcomesPeregrine G Green, Pieter R Stella, Indulis Kumsārs, et al.
Journal of the American College of Cardiology|September 27, 2018
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting StentsDavid E Kandzari, Jacques J Koolen, Gheorghe Doros, et al.
Scientific Reports|July 5, 2019
Increased levels of the megakaryocyte and platelet expressed cysteine proteases stefin A and cystatin A prevent thrombosisAnna Mezzapesa, Delphine Bastelica, Lydie Crescence, et al.
The Journal of Invasive Cardiology|December 17, 2021
Intracoronary Lithotripsy in Calcified Coronary Lesions: A Multicenter Observational StudyHicham El Jattari, Wouter Holvoet, Frederic De Roeck, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 17, 2024
Immediate or staged complete revascularisation in patients presenting with acute coronary syndrome by number of diseased vessels: a substudy of the BIOVASC randomised trialHala Kakar, Jacob J Elscot, Paola Scarparo, et al.
BMJ Open|October 23, 2018
Geriatric CO-mAnagement for Cardiology patients in the Hospital (G-COACH): study protocol of a prospective before-after effectiveness-implementation studyMieke Deschodt, Bastiaan Van Grootven, Anthony Jeuris, et al.
JACC. Cardiovascular Interventions|November 24, 2023
1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: The HighLife TSMVR Feasibility StudyLeonhard-Moritz Schneider, Stephen Worthley, Georg Nickenig, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome PatientsAriel Roguin, David E Kandzari, Erez Marcusohn, et al.
Lancet (London, England)|August 31, 2017
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trialDavid E Kandzari, Laura Mauri, Jacques J Koolen, et al.
Pageof 28